Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report
Abstrak
Abstract Background Complement component 3 (C3) glomerulopathy, which includes dense deposit disease (DDD) and C3 glomerulonephritis, is caused by dysregulation of the alternative complement pathway. In most cases, C3 glomerulopathy manifests pathologically with membranoproliferative glomerulonephritis-like features. An association between C3 glomerulopathy and monoclonal gammopathy was recently reported in several cases, raising the possibility that C3 glomerulopathy is the underlying pathological process in monoclonal gammopathy of renal significance. Case presentation We herein report a case of monoclonal gammopathy-induced DDD that improved histologically and clinically with chemotherapy including bortezomib. Our case is the first in which treatment response can be linked to the histological response. Potential pathological insights are also discussed. Conclusions Rapid and efficient chemotherapy has the potential to limit renal damage in monoclonal gammopathy-associated DDD.
Topik & Kata Kunci
Penulis (8)
Shuma Hirashio
Ayaka Satoh
Takahiro Arima
Kouichi Mandai
Tadasuke Awaya
Kumi Oshima
Shigeo Hara
Takao Masaki
Akses Cepat
- Tahun Terbit
- 2018
- Sumber Database
- DOAJ
- DOI
- 10.1186/s12882-018-0905-6
- Akses
- Open Access ✓